AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12212881 — intervention group
Group type: COMPARATOR
Intervention: Diet Coke
Number of subjects: 17
Study 9527749 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral spinal anaesthesia with 8 mg of hyperbaric bupivacaine 0.5%
Number of subjects: 20
Study 9527749 — intervention group
Group type: COMPARATOR
Intervention: Combined sciatico‐femoral nerve block with 7 mg kg(‐1) of mepivacaine 2%
Number of subjects: 20
Study 10150352 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive-sparing moisturizing cream, 0.1 mL applied to gloves
Number of subjects: 48
Study 10150352 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cream)
Number of subjects: 48
Study 2673080 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried chopped feverfew (70‐86 mg)
Number of subjects: 41
Study 2673080 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 41
Study 1067276 — intervention group
Group type: EXPERIMENTAL
Intervention: Interspace brush
Number of subjects: 35
Study 1067276 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-Dens
Number of subjects: 35
Study 1067276 — intervention group
Group type: EXPERIMENTAL
Intervention: Waxed dental floss
Number of subjects: 35
Study 30431649 — intervention group
Group type: EXPERIMENTAL
Intervention: Alliance and Rupture Observation Scale (AROS)
Number of subjects: 0
Study 28698476 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (50,000 IU)
Number of subjects: 49
Study 28698476 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 26110982 — intervention group
Group type: EXPERIMENTAL
Intervention: Cueing approach
Number of subjects: 31
Study 26110982 — intervention group
Group type: COMPARATOR
Intervention: Recasting approach
Number of subjects: 31
Study 24105072 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 μg ethinyl-estradiol (EE) with 3 mg drospirenone
Number of subjects: 30
Study 24105072 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 μg ethinyl-estradiol (EE) with 3 mg drospirenone
Number of subjects: 30
Study 24105072 — intervention group
Group type: COMPARATOR
Intervention: Both groups (20 μg EE and 30 μg EE)
Number of subjects: 30
Study 21777734 — intervention group
Group type: EXPERIMENTAL
Intervention: CERTIFECT™ (fipronil, amitraz, and (S)-methoprene)
Number of subjects: 16
Study 21777734 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 16
Study 20439553 — intervention group
Group type: EXPERIMENTAL
Intervention: Concord grape juice (CGJ) 480 mL daily for 12 weeks
Number of subjects: 76
Study 20439553 — intervention group
Group type: COMPARATOR
Intervention: Substitute grape-flavored drink (SGD) 480 mL daily for 12 weeks
Number of subjects: 76
Study 20439553 — intervention group
Group type: COMPARATOR
Intervention: No beverage (NTG)
Number of subjects: 76
Study 20439553 — intervention group
Group type: EXPERIMENTAL
Intervention: Concord grape juice (CGJ)
Number of subjects: 76
Study 17255252 — intervention group
Group type: EXPERIMENTAL
Intervention: NaDCC tablets
Number of subjects: 100
Study 17255252 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 14999359 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium (660 mg daily, 440 mg for patients ≥65 years)
Number of subjects: 100
Study 14999359 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (4000 mg daily)
Number of subjects: 100
Study 14999359 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 11682416 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 0.5 mg/kg
Number of subjects: 45
Study 11682416 — intervention group
Group type: EXPERIMENTAL
Intervention: Meperidine 0.5 mg/kg
Number of subjects: 45
Study 11682416 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline 15 or 20 mg
Number of subjects: 45
Study 9458416 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacemaker activated pacing
Number of subjects: 83
Study 9458416 — intervention group
Group type: COMPARATOR
Intervention: Pacemaker inactivated pacing
Number of subjects: 83
Study 7948797 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular morphine (0.2 mg/kg) and scopolamine (0.01 mg/kg)
Number of subjects: 44
Study 7948797 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral midazolam (0.75 mg/kg)
Number of subjects: 44
Study 3283766 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with Flutamide and LHRH agonist [D‐Trp]LHRH ethylamide
Number of subjects: 363
Study 3283766 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with Flutamide
Number of subjects: 363
Study 30106600 — intervention group
Group type: EXPERIMENTAL
Intervention: Clavicular hook plate (cHP)
Number of subjects: 73
Study 30106600 — intervention group
Group type: EXPERIMENTAL
Intervention: Double double-button suture (dDBS)
Number of subjects: 73
Study 26858013 — intervention group
Group type: EXPERIMENTAL
Intervention: Wii-Fit balance-based video games training
Number of subjects: 30
Study 26858013 — intervention group
Group type: COMPARATOR
Intervention: Conventional balance training (control group)
Number of subjects: 30
Study 24236573 — intervention group
Group type: EXPERIMENTAL
Intervention: All meal provision for 12 weeks
Number of subjects: 85
Study 24236573 — intervention group
Group type: COMPARATOR
Intervention: Self-directed diet for 12 weeks
Number of subjects: 85
Study 24236573 — intervention group
Group type: EXPERIMENTAL
Intervention: All meal provision after self-directed diet
Number of subjects: 85
Study 24236573 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal provision for a total of 24 weeks
Number of subjects: 85
Study 24236573 — intervention group
Group type: EXPERIMENTAL
Intervention: Groups switching diets
Number of subjects: 85
Study 23327968 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbonated Water (CW)
Number of subjects: 19
Study 23327968 — intervention group
Group type: COMPARATOR
Intervention: Water (W)
Number of subjects: 19
Study 20820150 — intervention group
Group type: EXPERIMENTAL
Intervention: Premedication consisting of 7.5 mg midazolam, 50 mg diclofenac, 1000 mg acetaminophen (orally) and fentanyl (intravenously)
Number of subjects: 209
Study 20820150 — intervention group
Group type: COMPARATOR
Intervention: Placebo medication
Number of subjects: 209
Study 19026887 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser activation using conical‐ended optical fibers with Er:YAG and Er,Cr:YSGG lasers
Number of subjects: 0
Study 19026887 — intervention group
Group type: EXPERIMENTAL
Intervention: Conical fibers
Number of subjects: 0
Study 19026887 — intervention group
Group type: COMPARATOR
Intervention: Er:YAG and Er,Cr:YSGG lasers
Number of subjects: 0
Study 16602172 — intervention group
Group type: EXPERIMENTAL
Intervention: High Intensity (HI) exercise
Number of subjects: 6
Study 16602172 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Intensity (LI) exercise
Number of subjects: 6
Study 16602172 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 6
Study 11817992 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose polyethylene glycol 3350 plus electrolytes (PEG+E)
Number of subjects: 0
Study 11817992 — intervention group
Group type: COMPARATOR
Intervention: Lactulose
Number of subjects: 0
Study 11817992 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG+E
Number of subjects: 0
Study 10632776 — intervention group
Group type: EXPERIMENTAL
Intervention: finasteride 5 mg daily for 24 months
Number of subjects: 28
Study 10632776 — intervention group
Group type: COMPARATOR
Intervention: placebo daily for 24 months
Number of subjects: 28
Study 7793211 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic suggestion (reassuring information focused on minimising postoperative nausea and vomiting)
Number of subjects: 70
Study 7793211 — intervention group
Group type: COMPARATOR
Intervention: Blank tape (control group)
Number of subjects: 70
Study 2019938 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol (0.10 mg/kg in 2 ml 0.9% saline solution)
Number of subjects: 83
Study 2019938 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol
Number of subjects: 83
Study 2019938 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline solution placebo
Number of subjects: 83
Study 6814298 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nitroglycerin (IV NTG) 0.5 micrograms/kg/min
Number of subjects: 20
Study 6814298 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nitroglycerin (IV NTG) 0.1 micrograms/kg/min
Number of subjects: 20
Study 6814298 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30765737 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-CHO-VE multivitamin treatment (DHA, choline, vitamin E)
Number of subjects: 30
Study 30765737 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-VD multivitamin treatment (DHA, vitamin D)
Number of subjects: 30
Study 30765737 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (control)
Number of subjects: 30
Study 30541606 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg lidocaine + 2 mg CPC
Number of subjects: 250
Study 30541606 — intervention group
Group type: COMPARATOR
Intervention: 1 mg lidocaine + 2 mg CPC
Number of subjects: 250
Study 27026311 — intervention group
Group type: EXPERIMENTAL
Intervention: 35 Gy to prostate (4-mm PTV margin)
Number of subjects: 258
Study 27026311 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 Gy to prostate (5-mm PTV margin)
Number of subjects: 258
Study 27026311 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 Gy to prostate/seminal vesicles (5-mm PTV margin)
Number of subjects: 258
Study 27026311 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal V38 (≥2.0 cm³)
Number of subjects: 258
Study 27026311 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of anticoagulants
Number of subjects: 258
Study 27026311 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of hemorrhoids
Number of subjects: 258
Study 27026311 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal V38 < 2.0 cm³ with anticoagulants or V38 ≥ 2.0 cm³ plus 1 other risk factor
Number of subjects: 258
Study 27026311 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall incidence of HH
Number of subjects: 258
Study 23825002 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise during bed rest
Number of subjects: 0
Study 23825002 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 0
Study 23825002 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 0
Study 22272750 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulfate (oral treatment for four weeks)
Number of subjects: 154
Study 22272750 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study 20023363 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 week multicomponent exercise training program
Number of subjects: 34
Study 20023363 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 34
Study 17405894 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular profiling for breast cancer management
Number of subjects: 0
Study 17405894 — intervention group
Group type: COMPARATOR
Intervention: Classic risk factors alone
Number of subjects: 0
Study 16181615 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 microg selenium/d
Number of subjects: 501
Study 16181615 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 microg selenium/d
Number of subjects: 501
Study 16181615 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 microg selenium/d
Number of subjects: 501
Study 16181615 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 501
Study 14687380 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertapenem 1 g once a day
Number of subjects: 351
Study 14687380 — intervention group
Group type: COMPARATOR
Intervention: Ceftriaxone 1 g once a day
Number of subjects: 351
Study 10955752 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular inhaled terbutaline (500-1000 microg four times daily)
Number of subjects: 52
Study 8832859 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound (US)
Number of subjects: 52
Study 8832859 — intervention group
Group type: COMPARATOR
Intervention: Conventional plain film radiography (CPF)
Number of subjects: 52
Study 1614781 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice, beans, and vegetable oil (group RB)
Number of subjects: 46
Study 1614781 — intervention group
Group type: COMPARATOR
Intervention: Rice, soy-protein isolate, corn syrup solids, and vegetable oil (group RS)
Number of subjects: 46
Study 6146499 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (four times a day)
Number of subjects: 10
Study 6146499 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol (once daily)
Number of subjects: 10
Study 6146499 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31206571 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulpectomy treatment with Maisto‐Capurro paste (G1)
Number of subjects: 46
Study 31206571 — intervention group
Group type: COMPARATOR
Intervention: Treatment with 3Mix‐MP paste (G2)
Number of subjects: 46
Study 29676928 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology applied 2 days a week for 3 weeks
Number of subjects: 64
Study 29676928 — intervention group
Group type: COMPARATOR
Intervention: Control group (no reflexology)
Number of subjects: 64
Study 27559969 — intervention group
Group type: EXPERIMENTAL
Intervention: High self-mastery (measured by Pearlin mastery score)
Number of subjects: 715
Study 27559969 — intervention group
Group type: COMPARATOR
Intervention: Frailty (defined by modified Fried criteria)
Number of subjects: 715
Study 27559969 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional decline
Number of subjects: 715
Study 27559969 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction between frailty and mastery
Number of subjects: 715
Study 24520674 — intervention group
Group type: EXPERIMENTAL
Intervention: Yuleshu oral mixture combined with conventional therapy
Number of subjects: 88
Study 24520674 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 88
Study 23006807 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori eradication therapy
Number of subjects: 347
Study 23006807 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 347
Study 20422846 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 90
Study 20422846 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 90
Study 17239325 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral interventions (progressive muscle relaxation training and systematic desensitization)
Number of subjects: 0
Study 17239325 — intervention group
Group type: COMPARATOR
Intervention: 5‐hydroxytryptamine type 3 receptor antagonists
Number of subjects: 0
Study 17239325 — intervention group
Group type: COMPARATOR
Intervention: Complementary and alternative methods (acupuncture and acupressure)
Number of subjects: 0
Study 16139580 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Vagus Nerve Stimulation (VNS)
Number of subjects: 235
Study 16139580 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 235
Study 12130963 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic tube compensation
Number of subjects: 21
Study 12130963 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure support ventilation
Number of subjects: 21
Study 12130963 — intervention group
Group type: COMPARATOR
Intervention: Continuous positive airway pressure
Number of subjects: 21
Study 10428520 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin 2% vaginal cream
Number of subjects: 168
Study 10428520 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 168
Study 7498208 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged sequential inflations (3 to 5 inflations of 3 to 5 min each, total duration > or = 12 min, group 1, n = 20 lesions)
Number of subjects: 41
Study 7498208 — intervention group
Group type: COMPARATOR
Intervention: Standard sequential inflations (3 to 5 inflations of < or = 1 min each, total duration < or = 3 min, group 2, n = 24 lesions)
Number of subjects: 41
Study 2188696 — intervention group
Group type: EXPERIMENTAL
Intervention: Day patient treatment
Number of subjects: 89
Study 2188696 — intervention group
Group type: COMPARATOR
Intervention: Inpatient treatment
Number of subjects: 89
Study 7040497 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumetanide (0.5 mg intravenous)
Number of subjects: 20
Study 7040497 — intervention group
Group type: COMPARATOR
Intervention: Furosemide (20 mg intravenous)
Number of subjects: 20
Study 30447172 — intervention group
Group type: EXPERIMENTAL
Intervention: Jaw Functional Limitation Scale (JFLS)
Number of subjects: 1372
Study 30447172 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental status stratified norms
Number of subjects: 1372
Study 28404973 — intervention group
Group type: EXPERIMENTAL
Intervention: L-asparaginase, cisplatin, etoposide, and dexamethasone (LVDP) plus concurrent chemoradiotherapy (CCRT)
Number of subjects: 66
Study 25692329 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibre Retention Osseous Resective Surgery (FibReORS)
Number of subjects: 30
Study 25692329 — intervention group
Group type: COMPARATOR
Intervention: Osseous Resective Surgery (ORS)
Number of subjects: 30
Study 24339273 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Training (GT) of the Otago Exercise Program (OEP) performed twice weekly for 12 weeks
Number of subjects: 125
Study 24339273 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Training (GT) of the Otago Exercise Program (OEP)
Number of subjects: 125
Study 24339273 — intervention group
Group type: COMPARATOR
Intervention: Home Training (HT) of the Otago Exercise Program (OEP) performed three times a week for 12 weeks
Number of subjects: 125
Study 24339273 — intervention group
Group type: COMPARATOR
Intervention: Home Training (HT) of the Otago Exercise Program (OEP)
Number of subjects: 125
Study 23326865 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren (150 mg)
Number of subjects: 14
Study 23326865 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren (300 mg)
Number of subjects: 14
Study 23326865 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril (5 mg)
Number of subjects: 14
Study 23326865 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril (10 mg)
Number of subjects: 14
Study 23326865 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 19236441 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin injection into normal tissue
Number of subjects: 8
Study 19236441 — intervention group
Group type: COMPARATOR
Intervention: Insulin injection into lipohypertrophic tissue
Number of subjects: 8
Study 19236441 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGMS) profiles for normal tissue
Number of subjects: 8
Study 19236441 — intervention group
Group type: COMPARATOR
Intervention: Continuous glucose monitoring (CGMS) profiles for lipohypertrophic tissue
Number of subjects: 8
Study 19236441 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection sites (normal vs lipohypertrophic)
Number of subjects: 8
Study 17589370 — intervention group
Group type: EXPERIMENTAL
Intervention: Marijuana (3.9% THC)
Number of subjects: 10
Study 17589370 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronabinol (10 mg)
Number of subjects: 10
Study 17589370 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronabinol (5 mg)
Number of subjects: 10
Study 17589370 — intervention group
Group type: EXPERIMENTAL
Intervention: Marijuana (2.0% THC)
Number of subjects: 10
Study 17589370 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 15683137 — intervention group
Group type: EXPERIMENTAL
Intervention: Declarative memory task
Number of subjects: 24
Study 15683137 — intervention group
Group type: COMPARATOR
Intervention: Nonlearning control task
Number of subjects: 24
Study 11641687 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 738
Study 11641687 — intervention group
Group type: COMPARATOR
Intervention: Intravenous analgesia
Number of subjects: 738
Study 9766292 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention for fatigue management
Number of subjects: 50
Study 8053585 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol at target blood concentration 2 micrograms/ml
Number of subjects: 6
Study 8053585 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol at target blood concentration 4 micrograms/ml
Number of subjects: 6
Study 8053585 — intervention group
Group type: COMPARATOR
Intervention: Epidural anesthesia alone (control)
Number of subjects: 6
Study 2903191 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified antihypertensive treatment aiming to lower diastolic blood pressure to less than or equal to 80 mmHg.
Number of subjects: 2000
Study 2903191 — intervention group
Group type: COMPARATOR
Intervention: Unchanged antihypertensive treatment.
Number of subjects: 2000
Study 31005904 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) + standard care
Number of subjects: 270
Study 31005904 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture + standard care
Number of subjects: 270
Study 31005904 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 270
Study 28483560 — intervention group
Group type: EXPERIMENTAL
Intervention: 12% carbohydrate-electrolyte beverage (CHO; 60g×500ml-1, Na+ 205mg×500ml-1)
Number of subjects: 15
Study 28483560 — intervention group
Group type: EXPERIMENTAL
Intervention: 12% carbohydrate-electrolyte beverage (CHO)
Number of subjects: 15
Study 28483560 — intervention group
Group type: COMPARATOR
Intervention: Water (Wat)
Number of subjects: 15
Study 28483560 — intervention group
Group type: COMPARATOR
Intervention: Placebo-electrolyte (PL)
Number of subjects: 15
Study 26377418 — intervention group
Group type: EXPERIMENTAL
Intervention: Communities That Care (CTC) prevention system
Number of subjects: 3986
Study 22890369 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone (IVTA) 4 mg/0.1 mL
Number of subjects: 27
Study 20731637 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (2 mg)
Number of subjects: 31
Study 20731637 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 19809604 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-duration VTE prophylaxis for 28 to 35 days
Number of subjects: 0